-ITI Board adds significant oncology drug development and commercialization expertise to the Board- May 05, 2020 08:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage ...
-Proceeds to support acceleration of Phase II clinical trial for GBM, advancement of pipeline, including development of COVID-19 vaccine candidate and expansion of opportunities for its UNITE nucleic acid platform- ...
GOLDEN, Colo., April 14, 2020 /PRNewswire/ -- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free injection system will be used to deliver a COVID-19 vaccine being ...
April 09, 2020 04:00 PM Eastern Daylight Time ROCKVILLE, Md. & PROVIDENCE, R.I. & GOLDEN, Colo.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study ...
Poster Title: Lysosomal-associated membrane protein-1-targeting of Epstein–Barr virus nuclear antigen 1 (EBNA1) elicits potent immune responses and inhibits tumor growth in preclinical studies by Dr. Pratima Sinha, Ph.D. Presentation Date: ...
Accelerate the Discovery, Translation & Clinical Development of Safe, Effective & Deliverable Therapies to Patients in Need Last December, 60+ thought-leaders including neuro-oncologists, neurosurgeons and oncology professionals from biopharma will ...
Society for NeuroOncology Annual Meeting Advancing multi-disciplinary brain tumor research, education, and collaboration to drive discovery and improve patient care https://soc-neuro-onc.org/SNO/News/2020_SNO_Annual_Meeting.aspx
The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on ...
About the Immuno-Oncology Summit Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across ...
When collaboration is more vital than ever, you can still rely on BIO to bring the industry together. For 2020, the BIO International Convention will transition to a new, virtual ...
Onco Cell Therapy Summit is dedicated to translating your novel data assets & IP into commercially viable oncological therapies. OCTS is a 4-track event and whilst bringing together the key ...
- Meeting on ITI-1001 Phase I program for treatment of Newly-Diagnosed Glioblastoma (GBM) - March 03, 2020 08:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., a privately held ...